Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof
US12280072B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 28, 2023 |
| Grant date | Apr 22, 2025 |
| Priority date | — |
| Expiry date | Sep 28, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08B37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A purified oligosaccharide compound having antithrombotic activity or a mixture of a homologous compound thereof and a pharmaceutically acceptable salt thereof, a preparation method for the mixture, a pharmaceutical composition containing the mixture, and uses thereof serving as an intrinsic factor X-enzyme (Xase) inhibitor in the preparation of drugs for preventing and/or treating thrombotic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.